Technical Insights on Cellceutix Corp (OTCBB:CTIX)

Repost This

Las Vegas, NV -- (SBWIRE) -- 07/10/2013 -- Cellceutix Corp (OTCBB:CTIX) was up 3.03% in its last trading session and closed at $1.70 per share.

In last one year the stock has been trading as low as $0.50 per share where the investors supported the stock, and it went up to its highest of $2.47 per share, where the stock price showed resistance. In its preceding session the stock has been trading between the range of $1.63 and $1.70 per share.

Cellceutix Corp.’s current traded volume stands at 50,280 which is significantly lower that the average volume of 204,086 for 30 days. At present the company is trading at a market valuation of $158.40 along with it holds 93.17 million shares.

Cellceutix Corp deals in small molecule drugs to treat diseases in the areas of cancer and inflammatory disease. The company was established in 2007 and is based in Massachusetts, USA.

To find out what OTCMAGIC projects for Cellceutix Corp for both short term and long term please click here: CTIX

OTCMAGIC Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in Hot Stocks!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at Release of Liability: Through use of this website viewing or using you agree to hold, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical., nor any of its affiliates are not registered investment advisors or broker dealers.